Skip to content

Treatment of Non-Alcoholic fatty liver disease by Virechana(Purgation therapy) and Vidangadi Kshara yoga.

A randomized comparative clinical trial to study the effect of Classical and Nitya Virechana followed by Internal administration of Vidangadi Kshara yoga in Non-Alcoholic fatty liver disease.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040355
Enrollment
20
Registered
2022-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Both freshly detected and previously diagnosed cases of NAFLD. USG findings are suggestive of NAFLD Grade I, II &III.

Exclusion criteria

Exclusion criteria: aged below 25 years and above 60 years, Pregnant women.Uncontrolled diabetes or hypertension, Complications of Metabolic syndrome-like Cerebrovascular accident, Myocardial Infarction, Chronic Kidney disease. Ayogya for Virechana karma in group A. Patients consume hepatotoxic medicines, alcohol, or other narcotic substances. Cirrhosis, Ascites, variceal hemorrhage, coagulopathy, hepatorenal syndrome. History of viral hepatitis, autoimmune liver diseases (Primary biliary cirrhosis, primary sclerosing cholangitis, autoimmune hepatitis), metabolic disorders (Wilson’s disease, hemochromatosis), HIV, TB other infectious diseases, malignancies, Major psychiatric problems.

Design outcomes

Secondary

MeasureTime frame
Changes in signs and symptoms of NAFLD. USG of Abdomen-changes of fatty liver and/or cholestasis. Changes in Hepatic profile (SGOT, SGPT, Direct, Indirect & Total Bilirubin & Serum alkaline phosphatase) Changes in Lipid profile. Changes in Total Serum Bile Acids.Timepoint: Patients will be assessed before treatment, after 15 days and after 30 days of Shamana.

Primary

MeasureTime frame
Samyaka Virikta Lakshana is to be assessed. Stool color, Stool odor, pH of stool after Virechana Karma. BMI - Before and after treatment. Changes in signs and symptoms of NAFLD. Timepoint: Patients will be assessed after 15 days (After completion of Virechana Karma).

Countries

India

Contacts

Public ContactDr R S Gandhi

Institute of Teaching and Research in Ayurveda Jamnagar

rsgandhi2003@yahoo.com9427451634

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026